Cargando…
Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?
Prognosticators evaluating survival in breast cancer vary in significance in respect to lymph node status. Studies have shown e.g. that HER2/neu immunohistochemistry or HER2/neu gene amplification analysis do perform well as prognosticators in lymph node positive (LN +) patients but are less valuabl...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1654187/ https://www.ncbi.nlm.nih.gov/pubmed/17092354 http://dx.doi.org/10.1186/1746-1596-1-41 |